Bluebird Bio Inc (BLUE)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Nick Leschly
Employees:
764
60 BINNEY STREET, CAMBRIDGE, MA 02142
339-499-9300

bluebird bio, Inc. is a clinical-stage biotechnology company. Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA.

Data derived from most recent annual or quarterly report
Market Cap 612.036 Million Shares Outstanding70.107 Million Avg 30-day Volume 2.49 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-3.58
Price to Revenue8.4147 Debt to Equity0.0 EBITDA-608.292 Million
Price to Book Value1.6941 Operating Margin-269.3104 Enterprise Value939.993 Million
Current Ratio5.32 EPS Growth0 Quick Ratio4.907
1 Yr BETA 0.5233 52-week High/Low 52.8 / 8.12 Profit Margin-257.3364
Operating Cash Flow Growth24.1411 Altman Z-Score-0.329 Free Cash Flow to Firm -460.286 Million

Are you looking for this stock instead?

View SEC Filings from BLUE instead.

View recent insider trading info

Funds Holding BLUE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BLUE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

24.4 Thousand total shares from 11 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EGGIMANN ANNE-VIRGINIE CHIEF REGULATORY OFFICER

26,610 2022-01-11 1

COLE JASON CHIEF OPERATING AND

  • LEGAL OFFICER
186,188 2022-01-10 8

LESCHLY NICK

736,427 2022-01-10 10

OBENSHAIN ANDREW PRESIDENT AND CEO

246,696 2022-01-10 10

WHITTEN JESSICA CHIEF ACCOUNTING OFFICER

49,413 2022-01-10 5

LYNCH DANIEL

  • Director
77,801 2021-11-11 2

DIXON WENDY L

  • Director
81,358 2021-11-11 2

GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER

  • Officer
193,816 2021-11-11 7

CONSYLMAN GINA CHIEF FINANCIAL OFFICER

  • Officer
271,040 2021-11-11 2

BAIRD WILLIAM D III CHIEF FINANCIAL OFFICER

  • Officer
101,559 2021-11-11 4

VACHON MARK

  • Director
42,087 2021-11-11 2

AGWUNOBI JOHN O

  • Director
44,951 2021-11-11 2

KLIMA THOMAS J CHIEF COMMERCIAL OFFICER

  • Officer
150,577 2021-11-11 3

GLICKMAN SARAH JS

  • Director
0 2021-11-11 3

SELLERS WILLIAM R.

  • Director
14,430 2021-11-11 2

IBRAHIM RAMY

  • Director
0 2021-11-11 2

TORRES DENICE

  • Director
7,156 2021-11-11 2

LEIDERMAN ELISABETH

  • Director
24,418 2021-11-11 3

MAUS MARCELA V.

  • Director
0 2021-11-11 3

TITA-REID NAJOH

  • Director
24,418 2021-11-11 3

DAVIDSON DAVID CHIEF MEDICAL OFFICER

47,787 2021-04-05 4

BURNETT KATY PRINCIPAL ACCOUNTING OFFICER

4,097 2021-02-16 1

SMITH-FARRELL JOANNE COO, ONCOLOGY

20,609 2021-01-05 0

FINGER ALISON CECILY CHIEF COMMERCIAL OFFICER

25,103 2021-01-05 0

WENTWORTH KORY JAMES PRINCIPAL ACCOUNTING OFFICER

9,512 2020-08-03 0

MELTON DOUGLAS

6,324 2020-06-18 0

SCHENKEIN DAVID P

6,832 2020-06-18 0

WALSH JEFFREY T. CHIEF STRATEGY OFFICER

  • Officer
40,921 2019-08-20 0

HIGH SUSANNA GATTI CHIEF OPERATING OFFICER

  • Officer
13,735 2018-12-06 0

MANDELL JAMES

  • Director
1,000 2018-09-10 0

HEDLEY MARY LYNNE

  • Director
3,700 2018-06-20 0

MARAGANORE JOHN

  • Director
5,843 2017-09-14 0

SULLIVAN ERIC PRINCIPAL ACCOUNTING OFFICER

  • Officer
5,974 2017-08-03 0

GILLIS STEVEN

  • Director
109,308 2015-07-28 0

FINER MITCHELL H. CHIEF SCIENTIFIC OFFICER

  • Officer
0 2015-06-01 0

TEPPER ROBERT I

  • Director
  • 10% Owner
89,017 2015-02-03 0

THIRD ROCK VENTURES LP

THIRD ROCK VENTURES GP, L.P.

TRV GP, LLC

  • 10% Owner
No longer subject to file 2015-02-03 0

DETORE JAMES M. CHIEF FINANCIAL OFFICER

  • Officer
0 2014-12-01 0

BAIN LINDA VP, FIN. & BUSINESS OPERATIONS

  • Officer
0 2014-02-26 0

TVM V LIFE SCIENCE VENTURES GMBH & CO KG

TVM CAPITAL GMBH

POLACK AXEL

SCHUHSLER HELMUT

GOLL ALEXANDRA

BIRNER HUBERT

FISCHER STEFAN

  • 10% Owner
2,254,357 2013-06-24 0

ARCH VENTURE FUND VII LP

ARCH VENTURE PARTNERS VII, L.P.

ARCH VENTURE PARTNERS VII, LLC

BYBEE CLINTON

CRANDELL KEITH

NELSEN ROBERT

  • 10% Owner
No longer subject to file 2013-06-24 0

MULDER GEERT-JAN

  • Director
No longer subject to file 2013-06-24 0

POLACK AXEL

  • Director
2,254,357 2013-06-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

COLE JASON CHIEF OPERATING AND LEGAL OFFICER

2022-01-12 21:15:40 -0500 2022-01-11 S 3,387 $9.64 d 186,188 direct 2.4648 2.4648 2 0.0 1

OBENSHAIN ANDREW PRESIDENT AND CEO

2022-01-12 21:15:21 -0500 2022-01-11 S 4,683 $9.64 d 246,696 direct 2.4648 2.4648 2 0.0 1

WHITTEN JESSICA CHIEF ACCOUNTING OFFICER

2022-01-12 21:16:12 -0500 2022-01-11 S 279 $9.64 d 49,413 direct 2.4648 2.4648 2 0.0 1

LESCHLY NICK

2022-01-12 21:15:29 -0500 2022-01-11 S 5,068 $9.64 d 281,330 direct 2.4648 2.4648 2 0.0 1

OBENSHAIN ANDREW PRESIDENT AND CEO

2022-01-12 21:15:21 -0500 2022-01-10 S 852 $9.24 d 253,569 direct 2.4648 2.4648 2 0.0 1

LESCHLY NICK

2022-01-12 21:15:29 -0500 2022-01-10 S 2,369 $9.40 d 286,398 direct 2.4648 2.4648 2 0.0 1

COLE JASON CHIEF OPERATING AND LEGAL OFFICER

2022-01-12 21:15:40 -0500 2022-01-10 S 1,584 $9.40 d 189,575 direct 2.4648 2.4648 2 0.0 1

OBENSHAIN ANDREW PRESIDENT AND CEO

2022-01-12 21:15:21 -0500 2022-01-10 S 2,190 $9.40 d 251,379 direct 2.4648 2.4648 2 0.0 1

WHITTEN JESSICA CHIEF ACCOUNTING OFFICER

2022-01-12 21:16:12 -0500 2022-01-10 S 130 $9.40 d 49,692 direct 2.4648 2.4648 2 0.0 1

WHITTEN JESSICA CHIEF ACCOUNTING OFFICER

2022-01-07 16:28:33 -0500 2022-01-05 S 2,984 $10.44 d 49,822 direct 1.7003 1.7003 2 0.0 1

WHITTEN JESSICA CHIEF ACCOUNTING OFFICER

2021-12-27 17:40:06 -0500 2021-12-22 A 9,502 a 52,806 direct -3.3426 -4.5497 0.0 1 -7.2423 4

OBENSHAIN ANDREW PRESIDENT AND CEO

2021-12-09 16:51:47 -0500 2021-12-07 S 832 $10.18 d 254,421 direct 6.1384 18.5268 18.5268 6 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BLUEBIRD BIO INC BLUE 2022-01-17 22:15:04 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 21:45:03 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 21:15:03 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 20:45:03 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 20:15:04 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 19:45:03 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 19:15:03 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 18:45:03 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 18:15:03 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 17:45:03 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 17:15:03 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 16:45:03 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 16:15:04 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 15:45:03 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 15:15:03 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 14:45:03 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 14:15:03 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 13:45:03 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 13:15:03 UTC -0.3604 0.4304 2000000
BLUEBIRD BIO INC BLUE 2022-01-17 12:45:03 UTC -0.3604 0.4304 2000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
American Century Quantitative Equity Funds, Inc.- AC Alternatives Equity Market Neutral Fund BLUE -1060.0 shares, $-93015.0 2019-12-31 N-PORT
American Century Quantitative Equity Funds, Inc.- Core Equity Plus Fund BLUE -1237.0 shares, $-113581.34 2019-09-30 N-PORT
AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund BLUE -552.0 shares, $-23885.04 2020-12-31 N-PORT
American Century Quantitative Equity Funds, Inc.- NT Core Equity Plus Fund BLUE -3131.0 shares, $-287488.42 2019-09-30 N-PORT
FundVantage Trust- Gotham Enhanced Index Plus Fund BLUE -181.0 shares, $-8318.76 2020-03-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund BLUE -213.0 shares, $-9789.48 2020-03-31 N-PORT
AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund BLUE -1199.0 shares, $-110092.18 2019-09-30 N-PORT
FundVantage Trust- Gotham Master Neutral Fund BLUE -3.0 shares, $-161.85 2020-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund BLUE -259.0 shares, $-11903.64 2020-03-31 N-PORT
AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF BLUE -15619.0 shares, $-298479.09 2021-09-30 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund BLUE -200.0 shares, $-3822.0 2021-09-30 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund BLUE -7570.0 shares, $-144662.7 2021-09-30 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund BLUE -748.0 shares, $-14294.28 2021-09-30 N-PORT

Elevate your investments